Special Diabetes Program Reauthorization Act of 2025
The Special Diabetes Program Reauthorization Act of 2025 reauthorizes two existing programs: the Special Diabetes Program for Type 1 Diabetes (SDPT1) and the Special Diabetes Program for Indians (SDPI). The bill extends federal funding for these programs through fiscal years 2026 and 2027, with a final short-term appropriation in late 2027. Specifically, it provides $160,000,000 for each program for 2026 and $160,000,000 for 2027, to remain available until expended, plus an additional $40,000,000 for the period October 1, 2027, through December 31, 2027, also to remain available until expended. The goal is to ensure continued support for diabetes research, treatment, and services under these programs. In short, the bill continues the two programs and sets explicit funding levels for 2026–2027 and a brief 2027 extension, rather than introducing new programmatic changes.
Key Points
- 1Reauthorizes two programs: SDPT1 and SDPI under the Public Health Service Act.
- 2For each program, sets $160,000,000 available for fiscal years 2026 and 2027.
- 3Adds a one-time 2027 funding boost of $40,000,000 for the period Oct 1, 2027, to Dec 31, 2027.
- 4Funds “to remain available until expended,” meaning unobligated funds can be used until fully spent.
- 5Title and sponsor information: Introduced in the Senate (S. 2211) on July 8, 2025, by Senator Collins (for herself and Senator Shaheen); status listed as Introduced.